CBAY

Cymabay Therapeutics

Delisted

CBAY was delisted on the 21st of March, 2024.

139 hedge funds and large institutions have $775M invested in Cymabay Therapeutics in 2023 Q1 according to their latest regulatory filings, with 42 funds opening new positions, 43 increasing their positions, 37 reducing their positions, and 20 closing their positions.

New
Increased
Maintained
Reduced
Closed
Holders
139
Holders Change
+21
Holders Change %
+17.8%
% of All Funds
2.22%
Holding in Top 10
10
Holding in Top 10 Change
+4
Holding in Top 10 Change %
+66.67%
% of All Funds
0.16%
New
42
Increased
43
Reduced
37
Closed
20
Calls
$6.51M
Puts
$3.42M
Net Calls
+$3.09M
Net Calls Change
+$1.8M
Name Holding Trade Value Shares
Change
Shares
Change %
JF
151
Jump Financial
Illinois
-$444K -70,801 Closed
Bank of Montreal
152
Bank of Montreal
Ontario, Canada
-$354K -56,276 Closed
Rockefeller Capital Management
153
Rockefeller Capital Management
New York
-$156K -25,000 Closed
Walleye Trading
154
Walleye Trading
New York
-$153K -24,412 Closed
QT
155
Quantamental Technologies
New York
-$93.5K -14,910 Closed
Ameriprise
156
Ameriprise
Minnesota
-$73K -11,561 Closed
Belvedere Trading
157
Belvedere Trading
Illinois
-$29.4K -4,695 Closed
S
158
SignatureFD
Georgia
-$727 -116 Closed